Cell Reports (May 2016)

Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells

  • Aaron Topol,
  • Shijia Zhu,
  • Brigham J. Hartley,
  • Jane English,
  • Mads E. Hauberg,
  • Ngoc Tran,
  • Chelsea Ann Rittenhouse,
  • Anthony Simone,
  • Douglas M. Ruderfer,
  • Jessica Johnson,
  • Ben Readhead,
  • Yoav Hadas,
  • Peter A. Gochman,
  • Ying-Chih Wang,
  • Hardik Shah,
  • Gerard Cagney,
  • Judith Rapoport,
  • Fred H. Gage,
  • Joel T. Dudley,
  • Pamela Sklar,
  • Manuel Mattheisen,
  • David Cotter,
  • Gang Fang,
  • Kristen J. Brennand

DOI
https://doi.org/10.1016/j.celrep.2016.03.090
Journal volume & issue
Vol. 15, no. 5
pp. 1024 – 1036

Abstract

Read online

Converging evidence indicates that microRNAs (miRNAs) may contribute to disease risk for schizophrenia (SZ). We show that microRNA-9 (miR-9) is abundantly expressed in control neural progenitor cells (NPCs) but also significantly downregulated in a subset of SZ NPCs. We observed a strong correlation between miR-9 expression and miR-9 regulatory activity in NPCs as well as between miR-9 levels/activity, neural migration, and diagnosis. Overexpression of miR-9 was sufficient to ameliorate a previously reported neural migration deficit in SZ NPCs, whereas knockdown partially phenocopied aberrant migration in control NPCs. Unexpectedly, proteomic- and RNA sequencing (RNA-seq)-based analysis revealed that these effects were mediated primarily by small changes in expression of indirect miR-9 targets rather than large changes in direct miR-9 targets; these indirect targets are enriched for migration-associated genes. Together, these data indicate that aberrant levels and activity of miR-9 may be one of the many factors that contribute to SZ risk, at least in a subset of patients.

Keywords